In addition, we show that some markers (like CD40L, NOX2, and 3NT) identified in the mouse models showed a pattern of step-wise upregulation in CHD patients by the presence of comorbidities such as hypertension or hypertension + diabetes. Here, CYBB is linked to hypertensive disorder.